Please login to the form below

Not currently logged in
Email:
Password:

Vernalis Therapeutics appoints president and COO

Sandford Sommer brings experience from AstraZeneca

UK-based Vernalis Therapeutics has appointed Sandford Sommer as its new president and chief operating officer.

Ian Garland, chief executive of Vernalis, said: “We are delighted to welcome Sandy to Vernalis at this exciting time as we build our US commercial operations.

“Sandy's depth of experience in sales and marketing, as well as in general management, make him ideally qualified to lead our US operations through this critical period of multiple product launches and rapid growth.”

Sommer joins the development stage pharmaceutical company from AstraZeneca, where he has spent the past 24 years in a series of increasingly senior roles.

Most recently, Sommer served as country president for AstraZeneca's operations in Colombia and prior to that was global vice president, CNS.

He has also served on the board of the UK Columbia Trade organisation since March 2014.

Sommer said: “I am excited to be joining Vernalis at such an important time.

“I am looking forward to the opportunity to contribute to the growth of the company's US business and to help rapidly advance the company's promising pipeline.”

3rd May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics